Direct therapeutic targeting of immune checkpoint PD-1 in pancreatic cancer

BACKGROUND: Pancreatic cancer (PC) hijacks innate cellular processes to promote cancer growth. We hypothesized that PC exploits PD-1/PD-L1 not only to avoid immune responses, but to directly enhance growth. We also hypothesized that immune checkpoint inhibitors (ICIs) have direct cytotoxicity in PC....

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Mei, Lin, Miranda, Moffitt, Richard A., Salazar, Marcela A., Park, Jinha, Vacirca, Jeffrey, Huang, Chuan, Shroyer, Kenneth R., Choi, Minsig, Georgakis, Georgios V., Sasson, Aaron R., Talamini, Mark A., Kim, Joseph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325157/
https://www.ncbi.nlm.nih.gov/pubmed/30377341
http://dx.doi.org/10.1038/s41416-018-0298-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6325157/
https://www.ncbi.nlm.nih.gov/pubmed/30377341
http://dx.doi.org/10.1038/s41416-018-0298-0

Ejemplares similares